Month: November 2017

Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer

South San Francisco, CA  November 29, 2017 Genentech Press Release – Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – SOUTH SAN FRANCISCO, CA — 2017-11-19 00:00:00 Genentech,…

December 2017 South San Francisco Library Events

South San Francisco, CA   November 29, 2017 Submitted by SSF Library ✔ eResource Newsletter Piece Did you know December is “Learn a Foreign Language Month?” Well, the Library can help you with that. Pronunciator is a fun and free…